EMEA-000978-PIP01-10-M01

Key facts

Invented name
Zelboraf
Active substance
vemurafenib
Therapeutic area
Oncology
Decision number
P/0210/2016
PIP number
EMEA-000978-PIP01-10-M01
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of melanoma
Route(s) of administration
Oral use
Contact for public enquiries
Roche Registration Limited
Switzerland
Tel. +41 6168794 11
Fax +41 616879411
E-mail: info.paediatrics@roche.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating